S&P 500
(-0.27%) 4 288.05 points
Dow J
(-0.47%) 33 508 points
(0.14%) 13 219 points
(0.39%) $91.14
(-1.02%) $2.90
(-0.31%) $1 860.40
(-1.67%) $22.08
(1.38%) 919.30
(0.06%) 0.946
(0.12%) 10.71
(0.08%) 0.820
(0.00%) 96.48

Realtime updates for Ainos, Inc. [AIMD]

Exchange: OTC Sector: Healthcare Industry: Biotechnology
Last Updated29 Sep 2023 @ 15:54

2.48% $ 0.620

Live Chart Being Loaded With Signals

Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications...

Today's Volume 6 001.00
Average Volume 254 261
Market Cap 12.58M
P/E -0.760
ATR14 $0.0250 (4.03%)

Ainos, Inc. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ainos, Inc. Financials

Annual 2022
Revenue: $3.52M
Gross Profit: $1.41M (39.93 %)
EPS: $-1.030
Q2 2023
Revenue: $28 555.00
Gross Profit: $-27 262.00 (-95.47 %)
EPS: $-0.120
Q1 2023
Revenue: $49 164.00
Gross Profit: $-51 684.00 (-105.13 %)
EPS: $-0.130
Q4 2022
Revenue: $1.04M
Gross Profit: $459 815 (44.30 %)
EPS: $-0.160

Ainos, Inc.

Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.

AIMD Next Dividend
(Unknown) $0 Probabilty 0 %
Quarter Ratio
AIMD 0.00 0.00
Pay Frequency
AIMD Insufficient data to determine frequency 0
Yearly Payout

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators


"Getagraph.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "Getagraph.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.
Total Execution Time: 5.3917109966278 seconds
Number of API calls: 2
Number of DB calls: 9